Xeris Biopharma Holdings, Inc. (XERS)

Xeris Biopharma Holdings Revenue

In the year 2025, Xeris Biopharma Holdings had annual revenue of $291.85M with 43.72% growth. Xeris Biopharma Holdings had revenue of $85.81M in the quarter ending December 31, 2025, with 42.78% growth.

• Revenue (ttm): $291.85M
• Revenue Growth: +43.72%
• P/S Ratio: 3.30
• Revenue / Employee: $670,908
• Employees: 435
• Market Cap: 967.34M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	291.85M	88.78M	43.72%
Dec 31, 2024	203.07M	39.16M	23.89%
Dec 31, 2023	163.91M	53.67M	48.68%
Dec 31, 2022	110.25M	60.66M	122.32%
Dec 31, 2021	49.59M	29.16M	142.67%
Dec 31, 2020	20.44M	17.71M	650.73%
Dec 31, 2019	2.72M	299.00K	12.34%
Dec 31, 2018	2.42M	867.00K	55.72%
Dec 31, 2017	1.56M	481.00K	44.74%
Dec 31, 2016	1.08M	-	-